Roles of Acyl-CoA: Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes

被引:63
作者
Li, Chen [1 ,2 ]
Li, Lena [1 ,3 ]
Lian, Jihong [1 ,3 ]
Watts, Russell [1 ,3 ]
Nelson, Randal [1 ,3 ]
Goodwin, Bryan [4 ]
Lehner, Richard [1 ,2 ,3 ]
机构
[1] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada
[2] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2S2, Canada
[3] Univ Alberta, Dept Pediat, Mazankowski Alberta Heart Inst, Edmonton, AB T6G 2S2, Canada
[4] Pfizer Global Res & Dev, Cardiovasc & Metab Dis Res Unit, Cambridge, MA USA
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
diacylglycerol o-acyltransferase; hepatocytes; triglycerides; LOW-DENSITY LIPOPROTEIN; LIPID DROPLET EXPANSION; DECREASES BLOOD-LIPIDS; RAT-LIVER MICROSOMES; APOLIPOPROTEIN-B; HEPG2; CELLS; FATTY-ACID; HEPATIC STEATOSIS; TRIGLYCERIDE SYNTHESIS; ENDOPLASMIC-RETICULUM;
D O I
10.1161/ATVBAHA.114.304584
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Very low-density lipoprotein assembly and secretion are regulated by the availability of triacylglycerol. Although compelling evidence indicates that the majority of triacylglycerol in very low-density lipoprotein is derived from re-esterification of lipolytic products released by endoplasmic reticulum-associated lipases, little is known about roles of acyl-CoA: diacylglycerol acyltransferases (DGATs) in this process. We aimed to investigate the contribution of DGAT1 and DGAT2 in lipid metabolism and lipoprotein secretion in primary mouse and human hepatocytes. Approach and Results-We used highly selective small-molecule inhibitors of DGAT1 and DGAT2, and we tracked storage and secretion of lipids synthesized de novo from [H-3] acetic acid and from exogenously supplied [3H] oleic acid. Inactivation of individual DGAT activity did not affect incorporation of either radiolabeled precursor into intracellular triacylglycerol, whereas combined inactivation of both DGATs severely attenuated triacylglycerol synthesis. However, inhibition of DGAT2 augmented fatty acid oxidation, whereas inhibition of DGAT1 increased triacylglycerol secretion, suggesting preferential channeling of separate DGAT-derived triacylglycerol pools to distinct metabolic pathways. Inactivation of DGAT2 impaired cytosolic lipid droplet expansion, whereas DGAT1 inactivation promoted large lipid droplet formation. Moreover, inactivation of DGAT2 attenuated expression of lipogenic genes. Finally, triacylglycerol secretion was significantly reduced on DGAT2 inhibition without altering extracellular apolipoprotein B levels. Conclusions-Our data suggest that DGAT1 and DGAT2 can compensate for each other to synthesize triacylglycerol, but triacylglycerol synthesized by DGAT1 is preferentially channeled to oxidation, whereas DGAT2 synthesizes triacylglycerol destined for very low-density lipoprotein assembly.
引用
收藏
页码:1080 / 1091
页数:12
相关论文
共 58 条
  • [1] Evidence for triacylglycerol synthesis in the lumen of microsomes via a lipolysis-esterification pathway involving carnitine acyltransferases
    Abo-Hashema, KAH
    Cake, MH
    Power, GW
    Clarke, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (50) : 35577 - 35582
  • [2] AHN K, 2013, DIACYLGLYCEROL ACYLT
  • [3] Overexpression of diacylglycerol acyltransferase-1 reduces phospholipid synthesis, proliferation, and invasiveness in simian virus 40-transformed human lung fibroblasts
    Bagnato, C
    Igal, RA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) : 52203 - 52211
  • [4] As a Matter of Fat
    Brookheart, Rita T.
    Michel, Carlos I.
    Schaffer, Jean E.
    [J]. CELL METABOLISM, 2009, 10 (01) : 9 - 12
  • [5] Molecular mediators of hepatic steatosis and liver injury
    Browning, JD
    Horton, JD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) : 147 - 152
  • [6] DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis
    Buhman, KK
    Smith, SJ
    Stone, SJ
    Repa, JJ
    Wong, JS
    Knapp, FF
    Burri, BJ
    Hamilton, RL
    Abumrad, NA
    Farese, RV
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) : 25474 - 25479
  • [7] Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases
    Cao, Jingsong
    Zhou, Yingjiang
    Peng, Haibing
    Huang, Xinyi
    Stahler, Shannon
    Suri, Vipin
    Qadri, Ariful
    Gareski, Tiffany
    Jones, Juli
    Hahm, Seung
    Perreault, Mylene
    McKew, John
    Shi, Mengxiao
    Xu, Xin
    Tobin, James F.
    Gimeno, Ruth E.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (48) : 41838 - 41851
  • [8] Inhibition of triglyceride synthesis as a treatment strategy for obesity - Lessons from DGAT1-deficient mice
    Chen, HC
    Farese, RV
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (03) : 482 - 486
  • [9] Peroxisome Proliferator-activated Receptor-γ Coactivator-1α (PGC-1α) Stimulates VLDL Assembly through Activation of Cell Death-inducing DFFA-like Effector B (CideB)
    Chen, Zhouji
    Norris, Jin Y.
    Finck, Brian N.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (34) : 25996 - 26004
  • [10] Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance
    Choi, Cheol Soo
    Savage, David B.
    Kulkarni, Ameya
    Yu, Xing Xian
    Liu, Zhen-Xiang
    Morino, Katsutaro
    Kim, Sheene
    Distefano, Alberto
    Samuel, Varman T.
    Neschen, Susanne
    Zhang, Dongyan
    Wang, Amy
    Zhang, Xian-Man
    Kahn, Mario
    Cline, Gary W.
    Pandey, Sanjay K.
    Geisler, John G.
    Bhanot, Sanjay
    Monia, Brett P.
    Shulman, Gerald I.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (31) : 22678 - 22688